Cargando…
Genomic Characterization of High-Count MBL Cases Indicates that Early Detection of Driver Mutations and Subclonal Expansion are Predictors of Adverse Clinical Outcome
High-count monoclonal B-cell lymphocytosis (MBL) is an asymptomatic expansion of clonal B-cells in the peripheral blood without other manifestations of chronic lymphocytic leukemia (CLL). Yearly, 1% of MBLs evolve to CLL requiring therapy; thus being critical to understand the biologic events that d...
Autores principales: | Barrio, S., Shanafelt, T. D., Ojha, J., Chaffee, K. G., Secreto, C., Kortüm, K. M., Pathangey, S., Van-Dyke, D. L., Slager, S. L., Fonseca, R., Kay, N. E., Braggio, E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215040/ https://www.ncbi.nlm.nih.gov/pubmed/27469216 http://dx.doi.org/10.1038/leu.2016.172 |
Ejemplares similares
-
Risk of Non-hematologic Cancer in Individuals with High Count Monoclonal B-Cell Lymphocytosis (MBL)
por: Solomon, Benjamin M., et al.
Publicado: (2015) -
Differential prognosis of single and multiple TP53 abnormalities in high-count MBL and untreated CLL
por: Griffin, Rosalie, et al.
Publicado: (2023) -
Progression and survival of MBL: a screening study of 10 139 individuals
por: Slager, Susan L., et al.
Publicado: (2022) -
Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer
por: Hong, Matthew K.H., et al.
Publicado: (2015) -
Breast Tumors Maintain a Reservoir of Subclonal Diversity During Expansion
por: Minussi, Darlan Conterno, et al.
Publicado: (2021)